|
1
|
Meadows V, Kennedy L, Kundu D, Alpini G
and Francis H: Bile acid receptor therapeutics effects on chronic
liver diseases. Front Med (Lausanne). 7(15)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hirschfield GM, Heathcote EJ and Gershwin
ME: Pathogenesis of cholestatic liver disease and therapeutic
approaches. Gastroenterology. 139:1481–1496. 2010.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Black DD, Mack C, Kerkar N, Miloh T,
Sundaram SS, Anand R, Gupta A, Alonso E, Arnon R, Bulut P, et al: A
prospective trial of withdrawal and reinstitution of
ursodeoxycholic acid in pediatric primary sclerosing cholangitis.
Hepatol Commun. 3:1482–1495. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Chen HL, Wu SH, Hsu SH, Liou BY, Chen HL
and Chang MH: Jaundice revisited: Recent advances in the diagnosis
and treatment of inherited cholestatic liver diseases. J Biomed
Sci. 25(75)2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Mousa HS, Lleo A, Invernizzi P, Bowlus CL
and Gershwin ME: Advances in pharmacotherapy for primary biliary
cirrhosis. Expert Opin Pharmacother. 16:633–643. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lin GJ, Huang SH, Chen SJ, Wang CH, Chang
DM and Sytwu HK: Modulation by melatonin of the pathogenesis of
inflammatory autoimmune diseases. Int J Mol Sci. 14:11742–11766.
2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chen CQ, Fichna J, Bashashati M, Li YY and
Storr M: Distribution, function and physiological role of melatonin
in the lower gut. World J Gastroenterol. 17:3888–3898.
2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Huang Y, Xu C, He M, Huang W and Wu K:
Saliva cortisol, melatonin levels and circadian rhythm alterations
in Chinese primary school children with dyslexia. Medicine
(Baltimore). 99(e19098)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Joseph D, Chong NW, Shanks ME, Rosato E,
Taub NA, Petersen SA, Symonds ME, Whitehouse WP and Wailoo M:
Getting rhythm: How do babies do it? Arch Dis Child Fetal Neonatal
Ed. 100:F50–F54. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhang JJ, Meng X, Li Y, Zhou Y, Xu DP, Li
S and Li HB: Effects of melatonin on liver injuries and diseases.
Int J Mol Sci. 18(673)2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Li Y, Yu H, Xu Z, Shi S, Wang D, Shi X,
Wang Y, Zeng B, Deng H, Deng X and Zhong X: Melatonin ameliorates
ANIT-induced cholestasis by activating Nrf2 through a
PI3K/Akt-dependent pathway in rats. Mol Med Rep. 19:1185–1193.
2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yu H, Li Y, Xu Z, Wang D, Shi S, Deng H,
Zeng B, Zheng Z, Sun L, Deng X and Zhong X: Identification of
potential biomarkers in cholestasis and the therapeutic effect of
melatonin by metabolomics, multivariate data and pathway analyses.
Int J Mol Med. 42:2515–2526. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Fang ZZ, Tanaka N, Lu D, Jiang CT, Zhang
WH, Zhang C, Du Z, Fu ZW, Gao P, Cao YF, et al: Role of the
lipid-regulated NF-κB/IL-6/STAT3 axis in alpha-naphthyl
isothiocyanate-induced liver injury. Arch Toxicol. 91:2235–2244.
2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Dahm LJ and Roth RA: Protection against
alpha-naphthylisothiocyanate-induced liver injury by decreased
hepatic non-protein sulfhydryl content. Biochem Pharmacol.
42:1181–1188. 1991.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wang BL, Zhang CW, Wang L, Tang KL, Tanaka
N, Gonzalez FJ, Xu Y and Fang ZZ: Lipidomics reveal aryl
hydrocarbon receptor (Ahr)-regulated lipid metabolic pathway in
alpha-naphthyl isothiocyanate (ANIT)-induced intrahepatic
cholestasis. Xenobiotica. 49:591–601. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Tjandra K, Sharkey KA and Swain MG:
Progressive development of a Th1-type hepatic cytokine profile in
rats with experimental cholangitis. Hepatology. 31:280–290.
2000.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Connolly AK, Price SC, Connelly JC and
Hinton RH: Early changes in bile duct lining cells and hepatocytes
in rats treated with alpha-naphthylisothiocyanate. Toxicol Appl
Pharmacol. 92:208–219. 1988.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Mateos J, Estévez O, González-Fernández Á,
Anibarro L, Pallarés Á, Reljic R, Mussá T, Gomes-Maueia C,
Nguilichane A, Gallardo JM, et al: Serum proteomics of active
tuberculosis patients and contacts reveals unique processes
activated during Mycobacterium tuberculosis infection. Sci Rep.
10(3844)2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Agafonov DE, Deckert J, Wolf E, Odenwälder
P, Bessonov S, Will CL, Urlaub H and Lührmann R: Semiquantitative
proteomic analysis of the human spliceosome via a novel
two-dimensional gel electrophoresis method. Mol Cell Biol.
31:2667–2682. 2011.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ylhä A, Nättinen J, Aapola U, Mikhailova
A, Nykter M, Zhou L, Beuerman R and Uusitalo H: Comparison of iTRAQ
and SWATH in a clinical study with multiple time points. Clin
Proteomics. 15(24)2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Bantscheff M, Schirle M, Sweetman G, Rick
J and Kuster B: Quantitative mass spectrometry in proteomics: A
critical review. Anal Bioanal Chem. 389:1017–1031. 2007.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Bantscheff M, Lemeer S, Savitski MM and
Kuster B: Quantitative mass spectrometry in proteomics: Critical
review update from 2007 to the present. Anal Bioanal Chem.
404:939–965. 2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Nakamura T, Ohta Y, Ohashi K, Ikeno K,
Watanabe R, Tokunaga K and Harada N: Protective effect of brazilian
propolis against liver damage with cholestasis in rats treated with
α-Naphthylisothiocyanate. Evid Based Complement Alternat Med.
2013(302720)2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ohta Y, Kongo-Nishimura M, Imai Y and
Kitagawa A: Melatonin attenuates disruption of serum cholesterol
status in rats with a single alpha-naphthylisothiocyanate
treatment. J Pineal Res. 42:159–165. 2007.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Chai J, Feng X, Zhang L, Chen S, Cheng Y,
He X, Yang Y, He Y, Wang H, Wang R and Chen W: Hepatic expression
of detoxification enzymes is decreased in human obstructive
cholestasis due to gallstone biliary obstruction. PLoS One.
10(e0120055)2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhang Y, Li F, Patterson AD, Wang Y,
Krausz KW, Neale G, Thomas S, Nachagari D, Vogel P, Vore M, et al:
Abcb11 deficiency induces cholestasis coupled to impaired β-fatty
acid oxidation in mice. J Biol Chem. 287:24784–24794.
2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Tan DS and Russel RJ: Mitochondria: The
birth place, battle ground and the site of melatonin metabolism in
cells. Melatonin Res. 2:44–66. 2019.
|
|
28
|
Chen HH, Chen YT, Yang CC, Chen KH, Sung
PH, Chiang HJ, Chen CH, Chua S, Chung SY, Chen YL, et al: Melatonin
pretreatment enhances the therapeutic effects of exogenous
mitochondria against hepatic ischemia-reperfusion injury in rats
through suppression of mitochondrial permeability transition. J
Pineal Res. 61:52–68. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Caldwell S: NASH Therapy: Omega 3
supplementation, vitamin E, insulin sensitizers and statin drugs.
Clin Mol Hepatol. 23:103–108. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Perumpail BJ, Cholankeril R, Yoo ER, Kim D
and Ahmed A: An overview of dietary interventions and strategies to
optimize the management of non-alcoholic fatty liver disease.
Diseases. 5(23)2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yang H, Ramani K, Xia M, Ko KS, Li TW, Oh
P, Li J and Lu SC: Dysregulation of glutathione synthesis during
cholestasis in mice: Molecular mechanisms and therapeutic
implications. Hepatology. 49:1982–1991. 2009.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Burhans MS, Flowers MT, Harrington KR,
Bond LM, Guo CA, Anderson RM and Ntambi JM: Hepatic oleate
regulates adipose tissue lipogenesis and fatty acid oxidation. J
Lipid Res. 56:304–318. 2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Tong L: Acetyl-coenzyme A carboxylase:
Crucial metabolic enzyme and attractive target for drug discovery.
Cell Mol Life Sci. 62:1784–1803. 2005.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Easlon E, Tsang F, Skinner C, Wang C and
Lin SJ: The malate-aspartate NADH shuttle components are novel
metabolic longevity regulators required for calorie
restriction-mediated life span extension in yeast. Genes Dev.
22:931–944. 2008.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kim EY, Kim WK, Kang HJ, Kim JH, Chung SJ,
Seo YS, Park SG, Lee SC and Bae KH: Acetylation of malate
dehydrogenase 1 promotes adipogenic differentiation via activating
its enzymatic activity. J Lipid Res. 53:1864–1876. 2012.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Rudraiah S, Zhang X and Wang L: Nuclear
receptors as therapeutic targets in liver disease: Are we there
yet? Annu Rev Pharmacol Toxicol. 56:605–626. 2016.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Halilbasic E, Baghdasaryan A and Trauner
M: Nuclear receptors as drug targets in cholestatic liver diseases.
Clin Liver Dis. 17:161–189. 2013.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Montagner A, Korecka A, Polizzi A, Lippi
Y, Blum Y, Canlet C, Tremblay-Franco M, Gautier-Stein A, Burcelin
R, Yen YC, et al: Hepatic circadian clock oscillators and nuclear
receptors integrate microbiome-derived signals. Sci Rep.
6(20127)2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Tan DX, Manchester LC, Esteban-Zubero E,
Zhou Z and Reiter RJ: Melatonin as a potent and inducible
endogenous antioxidant: Synthesis and metabolism. Molecules.
20:18886–18906. 2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Jaeschke H, Gores GJ, Cederbaum AI, Hinson
JA, Pessayre D and Lemasters JJ: Mechanisms of hepatotoxicity.
Toxicol Sci. 65:166–176. 2002.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Semak I, Korik E, Antonova M, Wortsman J
and Slominski A: Metabolism of melatonin by cytochrome P450s in rat
liver mitochondria and microsomes. J Pineal Res. 45:515–523.
2008.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Woolbright BL and Jaeschke H: Xenobiotic
and endobiotic mediated interactions between the Cytochrome P450
system and the inflammatory response in the liver. Adv Pharmacol.
74:131–161. 2015.PubMed/NCBI View Article : Google Scholar
|
